Invention Grant
- Patent Title: Cyclopropylamines as LSD1 inhibitors
-
Application No.: US15970954Application Date: 2018-05-04
-
Publication No.: US10676457B2Publication Date: 2020-06-09
- Inventor: Liangxing Wu , Wenqing Yao
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D417/14 ; C07D211/58 ; C07D401/14 ; C07D205/04 ; C07D211/34 ; C07D405/14 ; C07D405/12 ; C07D413/06 ; C07D211/98 ; C07D211/26 ; C07D403/04
Abstract:
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20190062301A1 CYCLOPROPYLAMINES AS LSD1 INHIBITORS Public/Granted day:2019-02-28
Information query
